Company Overview of Ranbaxy Pharmacie Generiques
Ranbaxy Pharmacie Génériques S.A.S. produces and sells pharmaceutical products in France. The company’s primary molecules include Oméprazole RPG, Amoxicilline/Acide, Clavulanique RPG, Simvastatine, Kétoprofène RPG, Xolaam, Flécaïnide RPG, Metformine RPG, Paroxétine RPG, Gabapantine RPG, and Amoxicilline RPG, as well as Fentanyl, Telmisartan, Tramadol, and Venlafaxine molecules. It offers its products in various therapeutic segments, such as oncology, gastrointestinal, neurology, pain management, pneumology, dermatology, diabetes, and allergology. The company is based in Puteaux, France. Ranbaxy Pharmacie Génériques S.A.S. is a subsidiary of Ranbaxy Laboratories Limited.
Immeuble Avant Seine
11-15 quai de Dion Bouton
33 1 41 44 44 50
33 1 41 44 44 90
Key Executives for Ranbaxy Pharmacie Generiques
Ranbaxy Pharmacie Generiques does not have any Key Executives recorded.
Similar Private Companies By Industry
|A.T.O. ZIZINE S.A.S||Europe|
|Advicenne Pharma SA||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Ranbaxy Pharmacie Generiques, please visit www.ranbaxy.fr. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.